AIDS Therapies
Once-Daily Dosing Holds Concentrations But With Side Effects
Published in AIDS Weekly, May 7th, 2001
These data were presented at the International Workshop on HIV Clinical Pharmacology in Noordwijk, The Netherlands, April 2-4, 2001.
"These studies with once-daily Fortovase plus ritonavir are in line with recent changes in U.S. HIV treatment guidelines, which supported the use of such boosted protease inhibitor regimens as a means of possibly simplifying dosing regimens and thus...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2001-05-07)
More Articles from AIDS Weekly
- AIDS Therapies
Zidovudine Derivative Much More Potent Than Parent Compound - At-Risk Populations
Many Heterosexuals Are Unaware Of HIV Risk Factors And Their Partner's HIV Status - AIDS Therapies
African Leaders Okay Plan To Import And Produce Generic HIV Drugs - AIDS Therapies
Antiretrovirals Can Raise Pediatric CD4 Count Despite Poor Viral Response - AIDS Therapies
Effective Dose Range For Once-Daily Protease Inhibitor Determined - HIV Transmission
Vaginal Infection Treatments Reduce Viral Load - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
